Get the Stockscreener App
8.64
4.85%
-0.44
Pre-market:
8.45
-0.19
-2.20%
Anika Therapeutics Inc stock is traded at $8.64, with a volume of 85,652.
It is down -4.85% in the last 24 hours and down -25.07% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
See More
Previous Close:
$9.08
Open:
$8.96
24h Volume:
85,652
Relative Volume:
0.78
Market Cap:
$124.57M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-1.7041
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
+5.11%
1M Performance:
-25.07%
6M Performance:
-51.62%
1Y Performance:
-65.84%
1-Day Range:
$8.5652
$9.19
1-Week Range:
$7.92
$9.25
52-Week Range:
$7.8701
$26.99
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.64 | 130.92M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
153.06 | 67.56B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.80 | 46.65B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.48B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.54 | 19.74B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.06 | 14.01B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | B. Riley Securities | Buy |
| Nov-01-24 | Reiterated | Barrington Research | Outperform |
| Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
Price momentum metrics for Anika Therapeutics Inc. explained2025 Market Sentiment & Expert Verified Movement Alerts - Newser
How to track smart money flows in Anika Therapeutics Inc.July 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
ANIK ALERT: Ongoing Investigation Into Anika Therapeutics, Inc.Contact Levi & Korsinsky - ACCESS Newswire
Published on: 2025-08-14 04:24:44 - Newser
Published on: 2025-08-14 03:22:26 - Newser
How Anika Therapeutics Inc. stock performs during market volatilityShort Setup & Daily Risk Controlled Trade Plans - Newser
Combining machine learning predictions for Anika Therapeutics Inc.July 2025 Fed Impact & Safe Investment Capital Preservation Plans - Newser
Technical analysis overview for Anika Therapeutics Inc. stockEarnings Recap Summary & Daily Entry Point Alerts - Newser
Anika Therapeutics faces investigation over potential securities fraud claims. - AInvest
How to manage a losing position in Anika Therapeutics Inc.Earnings Growth Summary & Long-Term Safe Investment Plans - Newser
Chart overlay techniques for tracking Anika Therapeutics Inc.Risk Aware Swing Trade Analysis Insights - Newser
How to track smart money flows in Anika Therapeutics Inc. [2025 Trading Recap]Free Entry Point Confirmation Signals - Newser
Lost Money on Anika Therapeutics, Inc. (ANIK)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Can Anika Therapeutics Inc. hit a new high this monthFree Real Time Alerts Based on AI Prediction - Newser
Applying big data sentiment scoring on Anika Therapeutics Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics - Bluefield Daily Telegraph
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues - GlobeNewswire
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Ongoing Anika Therapeutics, Inc. (ANIK) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire
Lost Money on Anika Therapeutics, Inc. (ANIK)? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - PR Newswire
What makes Anika Therapeutics Inc. stock price move sharplyAI Triggered Buy Zone Forecast System - Newser
Applying chart zones and confluence areas to Anika Therapeutics Inc.Free Accurate Technical Trend Reversal Picks - Newser
Why Anika Therapeutics Inc. stock attracts strong analyst attentionROI Focused Watchlist with Trade Confidence - Newser
Tools to assess Anika Therapeutics Inc.’s risk profileHigh Return Trade Roadmap with Setup Filters - Newser
Ongoing Securities Investigation into Anika Therapeutics, Inc. (ANIK)Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Launches Fraud Investigation on Behalf of Anika Therapeutics, Inc. (ANIK) Shareholders - ACCESS Newswire
What’s the recovery path for long term holders of Anika Therapeutics Inc.Risk Managed Watchlist with Breakout Picks - Newser
Anika Therapeutics Inc. stock momentum explainedFree Buy Signal Based on Chart Analysis - Newser
Anika Therapeutics shares rise 2.77% after-hours following positive clinical trial results for Hyalofast. - AInvest
ATTENTION ANIK Shareholders: Lost Money on Anika Therapeutics, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Anika Therapeutics: Undervalued HA Platform with 2027 Catalysts - AInvest
Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts (ANIK) - Seeking Alpha
Anika Therapeutics Inc. stock volume spike explainedFree Investment Strategy With Low Risk - Newser
Levi & Korsinsky Investigates Anika Therapeutics, Inc. (ANIK) Over Possible Securities Fraud - ACCESS Newswire
Anika Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price Following 26% Dive - simplywall.st
Published on: 2025-08-05 23:20:00 - Newser
Anika Therapeutics Under Investigation for Securities Fraud and Misleading Investors. - AInvest
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Anika Therapeutics, Inc. (ANIK) - ACCESS Newswire
ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
What are Anika Therapeutics Inc. company’s key revenue driversUnlock powerful stock screening for profits - Jammu Links News
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anika Therapeutics Inc Stock (ANIK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
1.29%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):